Gene · 2621
NIH grants2,018
NIH grants whose papers are about the gene, through NIH's grant-paper links.
1,821 to 1,840 of 2,018
Download this page as JSON| Grant | Title | GAS6 papers | Newest fiscal year |
|---|---|---|---|
| R01HL092071 | Cross-species analysis of myocardial susceptibility to perioperative stress | 1 | 2010 |
| R01LM006845 | Computational Gene Modeling and Genome Sequence Assembly | 1 | 2010 |
| R01NS062825 | Mechanisms Modulating Cytoskeletal Dynamics During Schwann Cell Myelination | 1 | 2010 |
| R03AR055701 | Impact of lupus susceptibility loci on peripheral tolerance and onset of disease | 1 | 2010 |
| R13NS070505 | 2010 NF Conference | 1 | 2010 |
| R21AG033387 | Longitudinal Analysis of Biomedical Imaging Data | 1 | 2010 |
| R21CA142537 | Reactivation of breast cancer micrometastases by senescent bone marrow stroma | 1 | 2010 |
| R21DE019953 | Novel Chimeric RNA Aptamer Technology to Treat Head and Neck Cancer | 1 | 2010 |
| R43CA137939 | MicroRNA therapeutics for prostate cancer | 1 | 2010 |
| R56DK042191 | Cytokines and Inflammatory Bowel Disease | 1 | 2010 |
| RC1CA144825 | Profiling and Characterizing Prostate Cancer Tumor Dormancy in the Bone Marrow | 1 | 2010 |
| RC1DK086364 | Development of the Cellular Biomarker for Diabetic Foot Ulcers | 1 | 2010 |
| RC1GM091083 | Phase I Clinical Trial Describing the Pharmacogenomics of Aspirin | 1 | 2010 |
| RC1HG005354 | Microlysis Technology: Enabling Cell Type-Specific Proteomics in Living Tissue | 1 | 2010 |
| RC2CA148346 | Predicting pancreatic cancer responses for a Parp inhibitor-based clinical trial | 1 | 2010 |
| RC2HL101621 | Genetic Mediators of Metabolic Cardiovascular Disease Risk | 1 | 2010 |
| S10RR023734 | Laser Scanning Confocal Microscope | 1 | 2010 |
| S10RR026802 | Univ of Utah Cell Sorter for Flow Cytometry Core | 1 | 2010 |
| U01AI068632 | International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) Group | 1 | 2010 |
| U01CA098233 | Characterizing Genetic Susceptibility to Breast and Prostate Cancer; the BPC3 | 1 | 2010 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2621/grants?page=92